Printer Friendly
The Free Library
19,102,419 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Nanosensors, Inc. Rated 'Speculative Buy' by Beacon Equity Research.


DALLAS -- Nanosensors, Inc. (OTCBB OTCBB

See OTC Bulletin Board (OTCBB).
:NNSR NNSR Notification of New Substances Regulations (United Kingdom) ) has been rated "Speculative Buy" by Beacon Equity Senior Research Analyst Dr. Victor Sula.

The full report is available at http://www.BeaconEquityResearch.com.

Anyone interested in receiving alerts regarding Nanosensors research should email members@beaconequityresearch.com with "NNSR" in the subject line.

In the report, Dr. Sula writes, "Nanosensors is focused on developing and commercializing sensors, instruments and intellectual property that will enable the creation of nanoscale devices. It operates in a unique market segment along with Thermo Fisher Scientific (NYSE NYSE

See: New York Stock Exchange
:TMO), eFoodSafety.com (OTC OTC

See: Over-the-counter.


OTC

See over-the-counter market (OTC).
:EFSF EFSF Earth Federation Space Force (Mobile Suit Gundam) .PK), JMAR JMAR Joint Medical Asset Repository  Technologies (OTCBB:JMAR), and Veeco Instruments (Nasdaq:VECO VECO Vernier Engine Cut Off )."

"The Company's current focus is building sensors that incorporate the technology covered by its license agreement with Michigan State University Michigan State University, at East Lansing; land-grant and state supported; coeducational; chartered 1855. It opened in 1857 as Michigan Agricultural College, the first state agricultural college.  to detect e.coli and salmonella in food and water. Previously, the Company was focused on developing sensors and instruments to detect chemical, explosive and biological agents with an in-house research and development group and product development team. While NNSR remains committed over the long-term to developing sensors and instruments for Homeland Security applications that employ advanced nano-technologies such as porous silicon and carbon nanotubes to detect malicious agents, the Company plans to drive near-term growth by acquiring technology licenses and assets."

Beacon Equity Research Disclosure

The analysts contributing to this report do not hold any shares of Nanosensors, Inc. (NNSR). Additionally, the analysts contributing to this report certify that the views expressed herein accurately reflect the analysts' personal views as to the subject securities and issuers. The analyst(s) writing this report recognize and aspire to all of the CFA Institute Guidelines for Independent Research. Beacon Equity Research ("Beacon") certifies that no part of the analysts' compensation was, is, or will be, directly or indirectly, related to the specific recommendation or views expressed by the analysts in the report. Beacon has directly been compensated seven thousand five hundred dollars by Ellipsis Communications for enrollment in its research program. This report is based on data obtained from sources we believe to be reliable, but is not guaranteed as to accuracy and does not purport to be complete. As such, the report should not be construed as advice designed to meet the particular investment needs of any investor. Any opinions expressed herein are subject to change.
COPYRIGHT 2007 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2007, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Feb 21, 2007
Words:377
Previous Article:Cognos and IBM Extend Strategic Alliance to Deliver On Demand Workforce Performance Management.
Next Article:Citigroup Property Investors Closes US$1.29 Billion CPI Capital Partners Asia Pacific, L.P. Fund.
Topics:



Related Articles
RocketCity Automotive Group Rated 'Speculative Buy,' by Beacon Equity Research.
Sun Sports and Entertainment Rated 'Speculative Buy,' Target Price $0.90 by Beacon Equity Research.
Lipid Labs, Inc. Rated 'Speculative Buy,' Target Price $1.05 by Beacon Equity Research.
Martin Nutraceuticals, Inc. Rated 'Speculative Buy,' Target Price $0.13 by Beacon Equity Research.
Imperia Entertainment, Inc. Rated 'Speculative Buy,' Target Price $0.40 by Beacon Equity Research.
PrimEdge, Inc. Rated 'Speculative Buy,' Target Price $4.00 by Beacon Equity Research.
Gemini Exploration Inc. Rated 'Speculative Buy,' Target Price $4.00 by Beacon Equity Research.
Worldwide Manufacturing USA, Inc. Rated 'Speculative Buy,' Target Price $9.50 by Beacon Equity Research.
Oramed Pharmaceuticals Rated 'Speculative Buy,' Target Price $1.20 by Beacon Equity Research.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles